CAJ | 학술논문

目的：探讨多入路联合介入治疗技术在复杂主-髂动脉硬化性闭塞症的应用。方法选取2011年6月至2013年6月在空军总医院住院的复杂主-髂动脉硬化性闭塞症15例，男性12例，女性3例，年龄55~85岁，平均年龄（68.6±10.2）岁。回顾性分析所有患者的病变位置、入路、操作手法、介入技术及治疗结果等相关资料。结果15例患者共20处闭塞病变行介入血管成型术，双侧股动脉联合入路8例，单侧肱动脉+单侧股动脉2例，单侧肱动脉+双侧股动脉5例。19处闭塞病变完全开通，1例闭塞病变内径恢复80%（因扩张疼痛，支架未能完全扩张），开通成功率100%。并且无严重并发症发生。结论多入路联合介入治疗复杂主-髂动脉硬化性闭塞症是安全、有效的，可以增加介入治疗成功率；合理的入路选择、多种操作技术的综合应用可以扩展主-髂动脉硬化性闭塞症的介入治疗范围。
목적：탐토다입로연합개입치료기술재복잡주-가동맥경화성폐새증적응용。방법선취2011년6월지2013년6월재공군총의원주원적복잡주-가동맥경화성폐새증15례，남성12례，녀성3례，년령55~85세，평균년령（68.6±10.2）세。회고성분석소유환자적병변위치、입로、조작수법、개입기술급치료결과등상관자료。결과15례환자공20처폐새병변행개입혈관성형술，쌍측고동맥연합입로8례，단측굉동맥+단측고동맥2례，단측굉동맥+쌍측고동맥5례。19처폐새병변완전개통，1례폐새병변내경회복80%（인확장동통，지가미능완전확장），개통성공솔100%。병차무엄중병발증발생。결론다입로연합개입치료복잡주-가동맥경화성폐새증시안전、유효적，가이증가개입치료성공솔；합리적입로선택、다충조작기술적종합응용가이확전주-가동맥경화성폐새증적개입치료범위。
Objective To discuss the application of multi-approach combining interventional therapy for treating complex aorta-iliac arteriosclerotic occlusion. Methods The patients were chosen (n=15, including male 12 and female 3) aged from 55 to 85 and average age was (68.6±10.2) from Jun. 2011 to Jun. 2013. The relative data of lesion locations, approaches, operating manipulations, intervention techniques and treatment results were retrospectively analyzed in all patients. Results There were 20 occlusions in 15 patients received interventional angioplasty, including 8 with bilateral femoral combined approaches, 2 with unilateral brachial artery-unilateral femoral combined approaches, and 5 with unilateral brachial-bilateral femoral combined approaches. The occlusion was fully opened in 19 cases and internal diameter was recovered by 80%in 1 case (stent was not fully expanded due to expansive pain). The success rate was 100%and there were no severe complications occurred. Conclusion Multi-approach combining interventional therapy for treating complex aorta-iliac arteriosclerotic occlusion is safe and effective, which can improve the success rate. The reasonable selection of approaches and comprehensive application of multi-operating technique can expand the therapeutic scale of international therapy in treatment of aorta-iliac arteriosclerotic occlusion.